196 related articles for article (PubMed ID: 31103998)
1. A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort.
Janssen S; Hansen HC; Dziggel L; Schild SE; Rades D
Radiol Oncol; 2019 May; 53(2):219-224. PubMed ID: 31103998
[TBL] [Abstract][Full Text] [Related]
2. A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer.
Rades D; Hansen HC; Schild SE; Janssen S
Lung; 2019 Jun; 197(3):321-326. PubMed ID: 30927058
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM.
Rades D; Sehmisch L; Hansen HC; Dziggel L; Janssen S; Schild SE
Anticancer Res; 2019 Mar; 39(3):1501-1505. PubMed ID: 30842188
[TBL] [Abstract][Full Text] [Related]
4. Estimating Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Whole-brain Radiotherapy With a New Tool.
Hansen HC; Janssen S; Schild SE; Rades D
Anticancer Res; 2019 Apr; 39(4):2091-2095. PubMed ID: 30952754
[TBL] [Abstract][Full Text] [Related]
5. Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer.
Heisterkamp C; Haatanen T; Schild SE; Rades D
Strahlenther Onkol; 2010 Feb; 186(2):70-75. PubMed ID: 20127223
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer.
Rades D; Hansen HC; Janssen S; Schild SE
Anticancer Res; 2019 May; 39(5):2569-2574. PubMed ID: 31092454
[TBL] [Abstract][Full Text] [Related]
7. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
8. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
Aoyama H; Tago M; Shirato H;
JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Diagnosis-Specific Survival Scores for Patients with Small-Cell Lung Cancer Irradiated for Brain Metastases.
Rades D; Hansen HC; Janssen S; Schild SE
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781513
[TBL] [Abstract][Full Text] [Related]
12. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
14. Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.
Jeene PM; de Vries KC; van Nes JGH; Kwakman JJM; Wester G; Rozema T; Braam PM; Zindler JD; Koper P; Nuyttens JJ; Vos-Westerman HA; Schmeets I; Niël CGHJ; Hutschemaekers S; van der Linden YM; Verhoeff JJC; Stalpers LJA
Acta Oncol; 2018 May; 57(5):637-643. PubMed ID: 29276848
[TBL] [Abstract][Full Text] [Related]
15. Comparison of nine prognostic scores in patients with brain metastases of breast cancer receiving radiotherapy of the brain.
Laakmann E; Riecke K; Goy Y; Kersten JF; Krüll A; Müller V; Petersen C; Witzel I
J Cancer Res Clin Oncol; 2016 Jan; 142(1):325-32. PubMed ID: 26424693
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.
Rades D; Meyners T; Veninga T; Stalpers LJ; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):404-8. PubMed ID: 20171794
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
18. Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis.
Zhang Q; Chen J; Yu X; Ma J; Cai G; Yang Z; Cao L; Chen X; Guo X; Chen J
J Neurooncol; 2013 Sep; 114(2):181-9. PubMed ID: 23743596
[TBL] [Abstract][Full Text] [Related]
19. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
20. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
Rades D; Heisterkamp C; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):398-403. PubMed ID: 20488627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
